Creative Medical Technology Holdings, Inc. Stock
Equities
CELZ
US22529Y4089
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.4 USD | -1.12% | +1.62% | -4.56% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 563K | Capitalization | 6.04M |
---|---|---|---|---|---|
Net income 2024 * | -4M | Net income 2025 * | -4M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 10.7 x |
P/E ratio 2024 * |
-1.35
x | P/E ratio 2025 * |
-1.72
x | Employees | 4 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.05% |
1 day | -1.12% | ||
1 week | +1.62% | ||
Current month | -0.90% | ||
1 month | -8.90% | ||
3 months | +2.09% | ||
6 months | +0.69% | ||
Current year | -4.56% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | 16-05-17 | |
Donald Dickerson
DFI | Director of Finance/CFO | 59 | 16-01-31 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Susan Snow
BRD | Director/Board Member | 67 | 21-12-01 |
Donald Dickerson
DFI | Director of Finance/CFO | 59 | 16-01-31 |
Chief Executive Officer | 63 | 16-05-17 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-20 | 4.4 | -1.12% | 973 |
24-05-17 | 4.45 | +2.53% | 2,137 |
24-05-16 | 4.34 | -1.36% | 3,889 |
24-05-15 | 4.4 | -0.90% | 1,693 |
24-05-14 | 4.44 | +2.54% | 6,206 |
Delayed Quote Nasdaq, May 20, 2024 at 10:39 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.56% | 6.04M | |
+9.77% | 115B | |
+11.85% | 106B | |
-2.88% | 21.96B | |
-14.11% | 21.87B | |
-5.29% | 19.21B | |
-3.02% | 18.08B | |
-38.57% | 17.71B | |
+6.38% | 14.32B | |
+35.48% | 12.42B |
- Stock Market
- Equities
- CELZ Stock